SAFETY AND EFFICACY OF ATEZOLIZUMAB, OBINUTUZUMAB AND VENETOCLAX COMBINATION FOR RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMAS: RESULTS FROM THE SAFETY‐RUN OF A LYSA STUDY. (12th June 2019) - Herbaux, C.; Feugier, P.; Tilly, H.; Salles, G.; Gressin, R.; Le Gouill, S.; Morschhauser, F.; Cartron, G.